Ali Saad | Health Professions | Best Researcher Award

Posted on by Book of Award

Prof. Ali Saad | Health Professions | Best Researcher Award

King Saud University | Saudi Arabia

Author Profile

Scopus

Orcid

Google Scholar

🎓 Early Academic Pursuits

Prof. Ali Saad embarked on a stellar academic journey with a Bachelor’s degree in Electrical Engineering from the University of Saint-Etienne, specializing in electronic and computer systems. He pursued advanced studies in Digital Image Processing, earning a Master’s and Ph.D. from prestigious French universities. His doctoral research on "Filtering and Unsupervised Segmentation of Polarimetric Radar Image" at the University of Nantes set the foundation for his expertise in image processing and electronics.

🧑‍🏫 Professional Endeavors

Prof. Saad has been an integral part of King Saud University since 2000, rising from Assistant Professor to Full Professor. Over two decades, he has enriched the academic fabric with courses in image processing, biomedical instrumentation, signal processing, and microcontroller programming. His teaching portfolio reflects his diverse knowledge and commitment to mentoring students across undergraduate and postgraduate levels.

📚 Contributions and Research Focus

Prof. Saad’s research spans innovative areas such as artificial intelligence in medical imaging, drug delivery models, and numerical analysis of two-phase flows. His recent work leverages AI for early brain tumor detection and nanoparticle visualization for nanomedicine. His contributions to computational methods, diagnostic tools, and medical systems underscore his role as a thought leader in applied sciences.

🏆 Accolades and Recognition

Prof. Saad’s achievements include international grants from NIH and ASTF, recognition by the Cambridge Blue Book, and awards for strategic planning at King Saud University. Notably, he played a pivotal role in KSU’s ABET accreditation and received certificates of appreciation from global organizations. His honorary memberships and accolades highlight his influence in academic and research circles.

🌍 Impact and Influence

Beyond academics, Prof. Saad has contributed to institutional excellence through leadership roles in quality assurance, accreditation, and strategic planning. His consultancy with the NCAAA and participation in academic advisory boards reflect his impact on higher education standards and policy formulation.

🌟 Legacy and Future Contributions

Prof. Ali Saad’s legacy lies in his interdisciplinary expertise, innovative teaching methodologies, and groundbreaking research. As a pioneer in merging AI and biomedical imaging, he continues to inspire the scientific community and shape the future of technology-driven solutions in healthcare. His dedication to advancing knowledge ensures his contributions will resonate for years to come.

 

Publications

📄 Optimal Air Flow Modeling in Real Healthcare Facilities for Quick Removal of Contaminated Air

  • Journal: Processes
  • Year: 2024
  • Authors: Omar Altwijri, Ravish Javed, Yousif A. Algabri, Fakhouri Abdulaziz Saud, Khaled Alqarni, Reema Altamimi, Sarah Alqahtani, Mohammed Almijalli, Ali Saad

📄 Novel Deep-Learning Approach for Automatic Diagnosis of Alzheimer’s Disease from MRI

  • Journal: Applied Sciences
  • Year: 2023
  • Authors: Omar Altwijri, Reem Alanazi, Adham Aleid, Khalid Alhussaini, Ziyad Aloqalaa, Mohammed Almijalli, Ali Saad

📄 Artificial Intelligence Approach for Early Detection of Brain Tumors Using MRI Images

  • Journal: Applied Sciences
  • Year: 2023
  • Authors: Adham Aleid, Khalid Alhussaini, Reem Alanazi, Meaad Altwaimi, Omar Altwijri, Ali Saad

📄 Estimation of SPIO Nanoparticles Uptakes by Macrophages Using Transmission Electron Microscopy

  • Journal: International Journal of Molecular Sciences
  • Year: 2022
  • Authors: Adham Aleid, Khalid Alhussaini, Mohammed Almijalli, Ali Saad

📄 Numerical Analysis for Two-Phase Flow with Non-Equilibrium Capillary Pressure in Anisotropic Porous Media

  • Journal: Advances in Computational Mathematics
  • Year: 2022
  • Authors: Ali Saad, Khaled Bouadjila, Ali Samir Saad, Mazen Saad, Wissal Mesfar

 

Dan Liu | Medicine and Dentistry | Best Researcher Award

Posted on by Book of Award

Dr. Dan Liu | Medicine and Dentistry | Best Researcher Award

General Hospital of Ningxia Medical University | China

Author Profile

Scopus

Orcid

🌱 Early Academic Pursuits

Dr. Dan Liu began her distinguished journey with a strong foundation in medicine and research. Her academic rigor led her to advanced positions, including her role as a doctoral supervisor and principal investigator. She gained international exposure as a visiting scholar at the University of Iowa and Texas Medical Center, further enhancing her global perspective and expertise in medical sciences.

💼 Professional Endeavors

Currently, Dr. Liu serves as the director of the Ningxia Hysteroscopy Diagnosis and Treatment Center and plays a pivotal role at the General Hospital of Ningxia Medical University. Her leadership in hysteroscopy diagnostics has transformed the medical landscape in Ningxia. Beyond clinical duties, she actively drives innovation and research, influencing medical sciences both regionally and nationally.

🔬 Contributions and Research Focus

Dr. Liu's research portfolio is impressive, including two projects funded by the National Natural Science Foundation of China and one significant national-grade project. She has successfully integrated technological advancements into her field, holding one utility model patent and one invention patent. Her pioneering contributions address critical challenges in women’s health, making significant strides in hysteroscopy techniques and diagnostics.

🏆 Accolades and Recognition

Dr. Liu’s accomplishments have garnered numerous awards, such as the prestigious second prize of the Science and Technology Progress Award of Ningxia Autonomous Region. In 2023, her dedication and exceptional service earned her the "Special Contribution" Award from People’s Daily Online, recognizing her as an excellent doctor. These accolades underscore her impact on medical innovation and patient care.

🌟 Impact and Influence

Through her dual roles in clinical practice and academia, Dr. Liu has shaped the next generation of medical professionals while advancing the field of hysteroscopy. Her leadership in research and treatment has set new benchmarks, directly benefiting patients and fostering a culture of innovation in the medical community.

🔮 Legacy and Future Contributions

As a trailblazer in her field, Dr. Liu’s legacy is one of excellence and commitment to advancing healthcare. Her ongoing projects and visionary leadership promise continued contributions to medical science, inspiring future researchers and clinicians to follow her path of innovation and service.

 

Publications

📝 Meta-analysis of FOXP3 polymorphisms and recurrent spontaneous abortion susceptibility
Authors: Shuai, R., Li, D., Xu, X., Yang, X., Liu, D.
Journal: American Journal of Reproductive Immunology
Year: 2024

📝 The osteogenesis and the biologic mechanism of thermo-responsive injectable hydrogel containing carboxymethyl chitosan/sodium alginate nanoparticles towards promoting osteal wound healing
Authors: Shi, Z., Yang, F., Pang, Q., Zhu, Y.
Journal: International Journal of Biological Macromolecules
Year: 2023

📝 Bone marrow mesenchymal stem cells combined with estrogen synergistically promote endometrial regeneration and reverse EMT via Wnt/β-catenin signaling pathway
Authors: Yuan, L., Cao, J., Hu, M., Chen, M., Liu, D.
Journal: Reproductive Biology and Endocrinology
Year: 2022

📝 A novel intrauterine barrier for preventing the recurrence of IUA after TCRA procedure
Authors: Chen, M., Yuan, L., Jin, H., Zhang, X., Liu, D.
Journal: Medical Hypotheses
Year: 2022

📝 Organoid Transplantation Can Improve Reproductive Prognosis by Promoting Endometrial Repair in Mice
Authors: Zhang, H., Xu, D., Li, Y., Li, G., Liu, D.
Journal: International Journal of Biological Sciences
Year: 2022

 

Shinya Watanabe | Neuroscience | Best Research Award

Posted on by Book of Award

Assist. Prof. Dr. Shinya Watanabe | Neuroscience | Best Research Award

University of Tsukuba | Japan 

Author Profile

Scopus

Orcid

Early Academic Pursuits 🎓

Dr. Shinya Watanabe’s academic journey began at Chiba University’s Department of Pharmaceutical Sciences. However, driven by a passion for medicine, he transitioned to the University of Tsukuba, earning a Bachelor’s degree in Medicine in 2005 and later a Ph.D. in Medicine in 2015. His diverse educational pursuits also include a specialized program in Medical Innovation Strategy at Chiba University, reflecting his commitment to integrating clinical expertise with innovative healthcare solutions.

Professional Endeavors 🩺

Dr. Watanabe’s illustrious medical career spans over two decades, marked by extensive hands-on experience across several leading hospitals in Japan. Starting as a resident at Tsukuba University Hospital, he later specialized as a neurosurgeon in institutions like Hitachi General Hospital and Tsukuba Medical Center. His tenure with the Pharmaceuticals and Medical Devices Agency (PMDA) between 2017 and 2020 saw him influencing drug, device, and regenerative medicine reviews, underscoring his role as a key figure in Japan’s medical regulatory landscape. Currently, he serves as a Lecturer at the University of Tsukuba’s Faculty of Medicine, contributing to both clinical practice and medical education.

Contributions and Research Focus 🔬

Dr. Watanabe’s research spans a variety of critical areas, including neurotrauma, cancer treatment, and dementia. His expertise has been certified by prestigious bodies such as the Japan Neurosurgical Society and the Japanese Society of Dementia. A thought leader in his field, Dr. Watanabe has actively developed innovative treatments, such as headache management techniques, and remains a sought-after expert in advancing medical technology and therapeutic strategies.

Accolades and Recognition 🏆

Dr. Watanabe’s exceptional contributions have been celebrated with numerous awards, such as the 12th Nose Award and the Research Encouragement Award from the Japanese Society for Diencephalo-Pituitary Tumors. In 2020, his groundbreaking interdisciplinary work earned him the Joyo Bank Award, highlighting his ability to bridge clinical practice with innovative technologies.

Impact and Influence 🌍

Through his extensive clinical and academic roles, Dr. Watanabe has shaped the practice of neurosurgery and medical device innovation in Japan. His contributions to the PMDA and ARO Council have had far-reaching effects, ensuring that healthcare products meet rigorous safety and efficacy standards. He has also inspired future generations of medical professionals through his dedication to education at the University of Tsukuba.

Legacy and Future Contributions 🌟

Dr. Watanabe’s legacy lies in his ability to blend clinical precision with innovation. As a pioneer in interdisciplinary research, he continues to push the boundaries of medical science, ensuring a brighter future for patients worldwide. His ongoing contributions to neuroscience, cancer treatment, and dementia care are set to redefine the standards of modern medicine, establishing him as a beacon of excellence in healthcare. With a career characterized by unwavering dedication and transformative achievements, Assist. Prof. Dr. Shinya Watanabe embodies the spirit of medical innovation and compassion.

 

Publications

📄"A Case of Idiopathic Intracranial Hypertension Complicated with both Infratentorial and Supratentorial Cortical Superficial Siderosis: Novel Imaging Findings on Intravoxel Incoherent Motion Magnetic Resonance Imaging Offering Clues to Pathophysiology"

  • Author: Watanabe, S.; Shibata, Y.; Ishikawa, E.
  • Journal: Neurology International
  • Year: 2024

📄"A Retrospective Cohort Study of Stereotactic Radiosurgery for Vestibular Schwannomas: Comparison of Two Age Groups (75 Years or Older vs. 65–74 Years)"

  • Author: Watanabe, S.; Yamamoto, M.; Aiyama, H.; Akutsu, H.; Ishikawa, E.
  • Journal: Surgical Neurology International
  • Year: 2024

📄"Recent Status of Phase I Clinical Trials for Brain Tumors: A Regulatory Science Study of Exploratory Efficacy Endpoints"

  • Author: Watanabe, S.; Nonaka, T.; Maeda, M.; Arakawa, Y.; Ishikawa, E.
  • Journal: Therapeutic Innovation and Regulatory Science
  • Year: 2024

📄"Empirical Myoelectric Feature Extraction and Pattern Recognition in Hemiplegic Distal Movement Decoding"

  • Author: Anastasiev, A.; Kadone, H.; Marushima, A.; Matsumaru, Y.; Ishikawa, E.
  • Journal: Bioengineering
  • Year: 2023

📄"Efficacy Endpoints in Phase II Clinical Trials for Meningioma: An Analysis of Recent Clinical Trials"

  • Author: Watanabe, S.; Nonaka, T.; Maeda, M.; Arakawa, Y.; Ishikawa, E.
  • Journal: Therapeutic Innovation and Regulatory Science
  • Year: 2023

 

Bin Zheng | Biomedicine | Best Researcher Award

Posted on by Book of Award

Prof. Dr. Bin Zheng | Biomedicine | Best Researcher Award

Tianjin University | China

Author Profile

Scopus

Orcid

Early Academic Pursuits 🌱

Prof. Dr. Bin Zheng’s academic journey began with a solid foundation in medical engineering and translational medicine. He further honed his expertise as a postdoctoral fellow at the Caroline School of Medicine, Sweden, laying the groundwork for a prolific career. His early pursuits in biomaterials and nanotechnology provided a strong base for his subsequent innovations and contributions to biomedical sciences.

Professional Endeavors 🏢

As a professor at Tianjin University's Academy of Medical Engineering and Translational Medicine, Dr. Zheng has led numerous research projects, including 10 completed and 6 ongoing endeavors. With over 30 impactful SCI publications, his work has gained recognition on a global scale. His collaborations with leading companies have fostered breakthroughs in cellular manufacturing and delivery technologies, enhancing both academic and industrial applications.

Contributions and Research Focus 🔬

Dr. Zheng’s work spans a wide range of fields, including biomaterials, cancer research, cellular microbiology, immunity, and nanobiotechnology. He has developed innovative therapeutic agents, including a nebulizable anti-bacterial spray targeting exosomes and stem cell extracts. His patents—70 published and 14 in progress—reflect his commitment to bridging the gap between laboratory research and clinical application.

Accolades and Recognition 🏆

Dr. Zheng’s outstanding contributions have earned him numerous awards, such as the Excellent Doctoral Dissertation of Tianjin Municipality and the First Prize for Innovative Achievements from the China Industry-University-Research Cooperation Association. Under his mentorship, graduate students have garnered over 20 prestigious awards, solidifying his role as an influential academic leader.

Impact and Influence 🌍

His research has been clinically translated and widely reported by media outlets like Science and Technology Daily and Science Net. As an editorial board member of prestigious journals, Dr. Zheng also influences the direction of global biomedical research. His international collaborations and contributions to standards like the Belt and Road LSEA 0006-2022 standard underscore his global impact.

Legacy and Future Contributions 🌟

Prof. Dr. Bin Zheng’s legacy lies in his innovative methodologies and translational focus, which continue to inspire the next generation of researchers. With ongoing projects in cutting-edge fields like optogenetics and cellular precision manufacturing, his future contributions are set to redefine the boundaries of medical engineering and translational medicine.

 

Publications

📄 Microorganism microneedle micro-engine depth drug delivery
Author(s): Zheng, B., Li, Q., Fang, L., Cheng, S.-X., Zhang, X.
Journal: Nature Communications
Year: 2024

📄 Near-infrared remote triggering of bio-enzyme activation to control intestinal colonization by orally administered microorganisms
Author(s): Sun, W., Yun, F., Guo, Q., Zheng, B., Ruan, X.
Journal: Acta Biomaterialia
Year: 2024

📄 Surface nanocoating-based universal platform for programmed delivery of microorganisms in complicated digestive tract
Author(s): Du, Y., Guo, H.L., Su, X., Wang, T., Zheng, B.
Journal: Journal of Colloid and Interface Science
Year: 2024

📄 A self-assembling bioactive oligopeptide hydrogel for the treatment of edema following prepuce surgery
Author(s): Liu, J., Pei, Y., Huang, Y., Chen, L., Zhou, Y.
Journal: Journal of Materials Chemistry B
Year: 2024

📄 NIR-Remote Selectively Triggered Buprenorphine Hydrochloride Release from Microneedle Patches for the Treatment of Neuropathic Pain
Author(s): Han, H., Li, B., Yang, R., Bai, Y., Yu, Y.
Journal: ACS Biomaterials Science and Engineering
Year: 2024

 

Yanhua Wang | Medicine and Dentistry | Best Researcher Award

Posted on by Book of Award

Dr. Yanhua Wang | Medicine and Dentistry | Best Researcher Award

Shanxi Aier Eye Hospital | China

Author Profile

Scopus

Orcid 

Early Academic Pursuits 📚

Dr. Yanhua Wang's journey in ophthalmology began with her Bachelor's degree in Clinical Medicine from Shanxi Changzhi Medical University in 1998. She pursued advanced studies, earning an MD in Ophthalmology and a PhD from Southwest Eye Hospital, General Medical University in Chongqing, China. Her academic trajectory was further enriched with a postdoctoral fellowship at the Department of Ophthalmology, General Hospital of PLA, Beijing, in 2013. This solid foundation equipped her with expertise in cutting-edge ophthalmic research and clinical care.

Professional Endeavors 💼

Dr. Wang's career spans over two decades, marked by her tenure as Deputy Chief Physician at Jinhzhong Hospital, Shanxi Province, where she served until 2016. Currently, she is the Chief Physician at the Department of Pediatric Ophthalmology & Optometry, Shanxi Aier Eye Hospital, part of the Aier Eye Hospital Group. Her role emphasizes innovative treatments and advanced care for pediatric ocular conditions, solidifying her as a leader in her field.

Contributions and Research Focus 🧠🔬

Dr. Wang’s research delves into the mechanisms underlying retinal neuron survival, optic nerve regeneration, and pediatric strabismus. Her studies on alpha-crystallin’s neuroprotective effects and its role in axonal regeneration have pioneered new therapeutic pathways. Through publications in journals such as Journal of Ophthalmology and Neuroscience Letters, she has significantly advanced understanding in these domains. She has also innovated patented technologies, including intelligent examination devices and surgical support structures, showcasing her dedication to translational research.

Accolades and Recognition 🏆

Dr. Wang has received numerous accolades, including the Chongqing Second Prize for Scientific and Technological Progress in 2013. She has secured major grants from prestigious institutions, such as the National Natural Science Foundation of China, the China Postdoctoral Science Foundation, and the Aier Eye Hospital Group Foundation. These honors reflect her impactful contributions to ophthalmology and translational medicine.

Impact and Influence 🌍

Dr. Wang’s work has had a profound influence on pediatric ophthalmology, offering novel diagnostic and therapeutic solutions for conditions like strabismus. Her patented inventions have enhanced clinical precision and patient outcomes, and her research has provided valuable insights into neuroprotection and nerve regeneration. Her leadership in clinical care and her scientific achievements continue to inspire and guide the next generation of ophthalmologists.

Legacy and Future Contributions 🌟

With her unwavering commitment to pediatric ophthalmology and groundbreaking research, Dr. Yanhua Wang's legacy is one of innovation and compassion. Her future contributions promise to bridge clinical advancements with cutting-edge research, ensuring better ocular health outcomes for children worldwide. Through her continued efforts, Dr. Wang is poised to leave an indelible mark on ophthalmology and medical science.

 

Publications

📝 Characteristics of Peripheral Retinal Refraction and Its Role in Children with Different Refractive States
Authors: Qi Zhao, Yanhua Wang*, Tiangang Liang, Weixiang Nie, Pei Xue, Jie Cheng
Journal: Journal of Ophthalmology
Year: 2024

📝 Synergistic Effect of Olfactory Ensheathing Cells and Alpha-Crystallin on Restoration of Adult Rat Optic Nerve Injury
Authors: Wang, Y.H., Yin, Z.Q., Wang, Y.
Journal: Neuroscience Letters
Year: 2017

📝 Leber's Hereditary Optic Neuropathy is Associated with Compound Primary Mutations of Mitochondrial ND1 m.3635G > A and ND6 m.14502 T > C
Authors: Jin, X., Wang, L., Gong, Y., Chen, T., Wei, S.
Journal: Ophthalmic Genetics
Year: 2015

📝 Alpha-Crystallin Promotes Rat Olfactory Ensheathing Cells Survival and Proliferation through Regulation of PI3K/Akt/mTOR Signaling Pathways
Authors: Wang, Y.H., Li, Y.C., Huo, S.J., Yin, Z.Q.
Journal: Neuroscience Letters
Year: 2012

📝 Alpha-Crystallin Promotes Rat Axonal Regeneration through Regulation of RhoA/Rock/Cofilin/MLC Signaling Pathways
Authors: Wang, Y.H., Wang, D.W., Wu, N., Wang, Y., Yin, Z.Q.
Journal: Journal of Molecular Neuroscience
Year: 2012

 

Inmaculada Gilaberte | Medicine and Dentistry | Best Researcher Award

Posted on by Book of Award

Dr. Inmaculada Gilaberte | Medicine and Dentistry | Best Researcher Award

FAES Farma | Spain

Author Profile

Scopus

🌱 Early Academic Pursuits

Dr. Inmaculada Gilaberte’s academic journey is rooted in a commitment to excellence and medical advancement. She initially pursued education in clinical research, equipping herself with in-depth knowledge and skills in therapeutic areas such as neuroscience and immunology. Her academic foundation was further strengthened by certifications, including a lecturer certification from the Spanish Quality Register Agency (ANECA), and advanced leadership programs from institutions like Stanford and MIT. These formative experiences shaped her growth mindset, laying the groundwork for a career dedicated to precision, patient-centered care, and effective team collaboration.

💼 Professional Endeavors

Throughout her career, Dr. Gilaberte has held prominent roles in major pharmaceutical companies such as FAES FARMA, Takeda, TiGenix, Roche, and Lilly, with positions spanning from Clinical Research Physician to Director of Clinical Research. She has led various departments, managed global teams, and directed clinical trials across multiple therapeutic areas, including gastroenterology, immunology, cardiology, and pain management. Her strategic guidance has driven several landmark projects forward, including the advancement of microbiome and cell therapies from preclinical to first-in-human trials, demonstrating her expertise in transforming innovative therapies into viable treatment options.

🧬 Contributions and Research Focus

Dr. Gilaberte has made notable contributions to clinical research, particularly in stem cell therapy, immunology, and neuroscience. Her pioneering work on Darvadstrocel, an allogeneic adipose-derived mesenchymal stem cell therapy, led to significant strides in treating perianal fistulas and positioned her as a leader in regenerative medicine. She has been instrumental in launching global clinical trials, developing target product profiles (TPP), and submitting regulatory applications for FDA and EMA approvals. With a robust publication record, including 66 papers indexed in PubMed, she continues to contribute to scientific literature, sharing her findings and advancing the field of biomedicine.

🏆 Accolades and Recognition

Dr. Gilaberte’s excellence has been recognized through numerous awards across her roles in clinical development and leadership. Her achievements include multiple awards for her work in the clinical progression of innovative therapies and successful drug submissions to global regulatory bodies. She has received recognition for her strategic contributions to the Darvadstrocel trials and for advancing neuroscience programs in Alzheimer’s disease. Her leadership has earned her high regard in the industry, with acknowledgments from institutions and colleagues alike.

🌍 Impact and Influence

Dr. Gilaberte’s impact extends beyond her immediate professional roles. Her contributions to clinical science have enhanced treatment options for patients with complex diseases, and her leadership has shaped clinical strategies in multinational pharmaceutical companies. She has also promoted effective collaboration across global, cross-functional teams, fostering a diverse and inclusive work environment that prioritizes patient needs. Her initiatives in regulatory compliance, risk management, and data integration have set new standards for clinical operations, solidifying her influence as a thought leader in her field.

📜 Legacy and Future Contributions

Looking ahead, Dr. Gilaberte’s legacy is one of commitment to advancing patient care through innovation, collaboration, and strategic foresight. Her future endeavors are poised to make an enduring impact, with ongoing research and leadership contributions that will shape the future of clinical development. Her philanthropic work, such as building a nursery in Uganda, highlights her dedication to global well-being beyond her professional achievements. Dr. Gilaberte continues to inspire the next generation of clinical researchers, ensuring that her legacy of precision, empathy, and patient-first innovation will endure.

 

Publications

📄 Efficacy and Safety of Weekly Calcifediol Formulations (75 and 100 µg) in Subjects with Vitamin D Deficiency: A Phase II/III Randomised Trial

  • Authors: Esteban Jódar-Gimeno, Jose Luis Pérez-Castrillón, Ján Nociar, Michal Lojka, Dimitar Nikolov, Fernando Cereto-Castro, Snežana Novković, Umberto Tarantino, Nadia Mehsen-Cetre, Paula Arranz, Cristina Martínez Ostalé, Aintzane García-Bea, Inmaculada Gilaberte
  • Journal: Nutrients
  • Year: 2024

📄 Comparative inhibition by oral bilastine, parenteral dexchlorpheniramine, and a new bilastine parenteral (i.v. and i.m.) formulation of histamine-induced wheal and flare response: A randomised phase I trial

  • Authors: Coimbra, J., Puntes, M., Molina, P., Arranz, P., Sánchez, C.
  • Journal: European Journal of Pharmaceutical Sciences
  • Year: 2024

📄  Bioequivalence and Safety of Bilastine 20 mg Orodispersible Tablets and Conventional Tablets: A Randomized, Single-Dose, Two-Period Crossover Study in Healthy Volunteers Under Fasting Conditions

  • Authors: Román, M., Ochoa, D., Martin, S., Arranz, P., Sánchez, C.
  • Journal: Drugs in R and D
  • Year: 2024

📄  Disease Burden, Treatment Patterns, and Economic Impact of Rectovaginal Fistulas in Patients with Crohn’s Disease: Findings from a Retrospective, Observational, Longitudinal Study Based on US Claims Databases

  • Authors: Karki, C., Latremouille-Viau, D., Gilaberte, I., Romdhani, H., Lightner, A.L.
  • Journal: PharmacoEconomics
  • Year: 2023

📄  Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn’s Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial

  • Authors: Garcia-Olmo, D., Gilaberte, I., Binek, M., Spinelli, A., Panés, J.
  • Journal: Diseases of the Colon and Rectum
  • Year: 2022

 

Yanqiu Huang | Health Professions | Best Researcher Award

Posted on by Book of Award

Dr. Yanqiu Huang | Health Professions | Best Researcher Award

Shanghai Jiaotong University School of Medicine| China

Author Profile

Orcid

Early Academic Pursuits 🎓

Dr. Yanqiu Huang began her academic journey in Preventive Medicine at Nanjing Medical University from 2017 to 2022. Her major courses included Epidemiology, Health Statistics, Environmental Hygiene, and Nutrition and Food Hygiene. Throughout her undergraduate studies, she demonstrated exceptional academic excellence, receiving several prestigious honors such as the National Scholarship, First Class Academic Scholarship, Dean Scholarship, and Public Health Scholarship. These early achievements laid a strong foundation for her career in public health.

Professional Endeavors 🏥

After completing her Bachelor's degree, Dr. Huang pursued a Doctor of Medicine in Public Health and Preventive Medicine at Shanghai Jiao Tong University from 2022 to 2024. During her PhD, she delved into advanced subjects such as Advanced Epidemiology, Oncology, Endocrinology, Metabolic Diseases, and Medical Statistics. Her exceptional performance in these areas earned her PhD First and Second Class Academic Scholarships. Dr. Huang's research during this period focused on public health challenges, particularly lifestyle and environmental factors affecting health outcomes.

Contributions and Research Focus 🔬

Dr. Huang has made significant contributions to the field of public health and preventive medicine. Her research primarily focuses on the role of lifestyle and nutrient intake on health, particularly in special populations. She has also explored Mendelian Randomization in digestive, neurodegenerative, and cardiovascular diseases, as well as the impact of air pollution on adverse health outcomes. Some of her notable publications include:

  • "Effect of Maternal Triclosan Exposure on Neonatal Birth Weight and Children Triclosan Exposure on BMI" (2021)
  • "Association Between Healthy Lifestyle Combinations and Periodontitis" (2024)
  • "Independent and Combined Effects of Smoking, Drinking, and Depression on Periodontal Disease" (2024)

Accolades and Recognition 🏆

Dr. Huang's academic and research accomplishments have been widely recognized. She has consistently received scholarships throughout her academic career, including the PhD First Class Academic Scholarship and PhD Second Class Academic Scholarship. Her publications in high-impact journals, such as Front Public Health and BMC Oral Health, have earned her a reputation as a rising star in public health research.

Impact and Influence 🌍

Dr. Huang’s research has made a significant impact on understanding the intersection of lifestyle, environmental factors, and health outcomes. Her studies have helped shape public health strategies by highlighting the importance of nutrient intake, pollution control, and healthy lifestyles in preventing diseases. Her work on Mendelian Randomization and its application to chronic diseases like cardiovascular and neurodegenerative conditions further contributes to global health knowledge.

Legacy and Future Contributions 🚀

Dr. Yanqiu Huang's academic achievements and research contributions position her as a future leader in preventive medicine. As she continues her work in public health research, her focus on lifestyle-mediated health outcomes and environmental influences will likely lead to new insights and solutions for improving global health. Her ongoing research and future publications will continue to influence policy and health initiatives worldwide, creating a lasting impact on the field.

 

Publications

📄 Association between Lifestyle Modification and All-Cause, Cardiovascular, and Premature Mortality in Individuals with Non-Alcoholic Fatty Liver Disease
Journal: Nutrients
Year: 2024
Contributors: Yanqiu Huang, Jinfan Xu, Yang Yang, Tingya Wan, Hui Wang, Xiaoguang Li

📄 The Combined Effects of the Most Important Dietary Patterns on the Incidence and Prevalence of Chronic Renal Failure: Results from the US National Health and Nutrition Examination Survey and Mendelian Analyses
Journal: Nutrients
Year: 2024
Contributors: Yanqiu Huang, Shiyu Xu, Tingya Wan, Xiaoyu Wang, Shuo Jiang, Wentao Shi, Shuai Ma, Hui Wang

📄 Association between Sleep and Periodontitis: NHANES 2009-2014 and Mendelian Randomization Study
Journal: CRANIO®
Year: 2024
Contributors: Yong Yuan, Xujie Miao, Yingqi Hou, Yanqiu Huang, Beibei Qiu, Wentao Shi

 

 

 

Paris Kantaras | Nursing and Health Professions | Best Researcher Award

Posted on by Book of Award

Mr. Paris Kantaras | Nursing and Health Professions | Best Researcher Award

Harokopio University | Greece

Author Profile

Orcid

Early Academic Pursuits 🎓

Mr. Paris Kantaras began his academic journey at the Technological Educational Institute of Crete in Greece, where he earned a Bachelor of Science in Nutrition and Dietetics in 2017. His undergraduate thesis focused on the reliability of the indirect calorimeter Vyntus CPX, demonstrating his early interest in practical applications of nutrition science. Mr. Kantaras furthered his education with a Master of Science in Medical Science (MMedSci) from the University of Glasgow, specializing in Human Nutrition with a focus on Clinical Nutrition. His distinguished dissertation explored the longitudinal relationship between the systematic inflammatory response and plasma antioxidants in critically ill patients, showcasing his deepening commitment to advancing knowledge in nutrition and dietetics. Currently, he is a Ph.D. candidate at Harokopio University in Greece, investigating dietary behaviors, lifestyle, and cardiometabolic risk factors across European families through the Feel4Diabetes intervention.

Professional Endeavors 🔍

In addition to his extensive education, Mr. Kantaras has garnered significant professional experience as a research associate at Harokopio University. His role involves coordinating several high-profile clinical trials, including the "Armadillo Trial," which examines the effects of infant formulas containing bioactive ingredients on growth and tolerance in healthy infants. He collaborates closely with principal investigators to ensure compliance with Good Clinical Practice (GCP) guidelines while actively participating in recruitment, data management, and monitoring the trial's integrity. His involvement in the Allergy Reduction Trial highlights his dedication to studying the long-term effects of nutrition interventions on allergic manifestations in children.

Contributions and Research Focus 📚

Mr. Kantaras has made notable contributions to the field of nutrition, particularly through his research on cardiometabolic risk factors and dietary behavior in families at high risk for type 2 diabetes. His published works, including studies on beverage consumption patterns and their association with metabolic health, illustrate his commitment to addressing significant health issues within diverse populations. By examining the intricate relationships between dietary choices, inflammation, and overall health, Mr. Kantaras is positioned at the forefront of clinical nutrition research. His ongoing projects aim to enhance understanding of how nutritional interventions can mitigate health risks and improve outcomes for vulnerable groups.

Accolades and Recognition 🏆

Throughout his academic and professional career, Mr. Kantaras has received numerous accolades that underscore his dedication to the field. His Master’s degree was awarded with Distinction, and his contributions to research have been recognized through his publications in reputable journals. His involvement in various clinical trials further solidifies his reputation as an emerging leader in nutrition research. Participation in prestigious conferences and his engagement in continuing professional development activities, including Good Clinical Practice training, further reflect his commitment to lifelong learning and excellence in his field.

Impact and Influence 🌍

Mr. Kantaras’s research has the potential to significantly impact public health, especially regarding diet-related chronic diseases such as obesity and diabetes. By addressing pressing issues like the nutritional needs of families at risk, his work influences health policies and clinical practices across Europe. His collaboration with international teams and participation in projects such as the Feel4Diabetes intervention enhance the applicability of his research findings, ensuring they reach a broader audience and inform effective dietary guidelines.

Legacy and Future Contributions 🌱

As Mr. Kantaras continues his Ph.D. studies and professional endeavors, he is poised to leave a lasting legacy in the field of nutrition and dietetics. His research aims not only to advance scientific knowledge but also to improve public health outcomes through evidence-based dietary interventions. By fostering collaborations and contributing to innovative studies, he will undoubtedly influence the future direction of nutrition research. His commitment to education and mentorship also hints at a future where he will inspire and shape the next generation of nutrition professionals.

 

Publications

📄Beverage Consumption Patterns and Their Association with Metabolic Health in Adults from Families at High Risk for Type 2 Diabetes in Europe—The Feel4Diabetes Study

Author: Paris Kantaras et al.
Journal: Endocrines
Year: 2024

📄Growth and Gut Comfort of Healthy Term Infants Exclusively Fed with a Partially Hydrolysed Protein-Based Infant Formula: A Randomized Controlled Double-Blind Trial

Author: Paris Kantaras et al.
Journal: Frontiers in Pediatrics
Year: 2024

📄Prevalence and Socioeconomic Correlates of Adult Obesity in Europe: The Feel4Diabetes Study

Author: Dimitrios V. Diamantis, Kalliopi Karatzi, Paris Kantaras et al.
Journal: International Journal of Environmental Research and Public Health
Year: 2022

 

Shadi Hamoud | Medicine and Dentistry | Best Researcher Award

Posted on by Book of Award

Assist Prof Dr. Shadi Hamoud | Medicine and Dentistry | Best Researcher Award

Rambam Health Care Campus | Israel

Author Profile

Orcid

Early Academic Pursuits 🎓

Dr. Shadi Hamoud's academic journey began with the completion of his MD (cum laude) from the Faculty of Medicine at the Hebrew University, Jerusalem, in 1995. His commitment to medical excellence was evident from the beginning, as he specialized in Internal Medicine during his residency at Rambam Medical Center from 1996 to 2002. His passion for teaching also emerged early, as he served as a tutor and lecturer for medical students and advanced nursing courses at Rambam Health Care Campus.

Professional Endeavors 🏥

Dr. Hamoud has held several key roles throughout his career. Since 2010, he has been the Director of the Clinical Research Unit at the Internal Medicine E Department, Rambam Medical Center. He also serves as the Deputy Director of the same department. His expertise is sought by major pharmaceutical companies such as Bayer and Pfizer, where he has been a medical consultant since 2016 and 2017, respectively. Additionally, Dr. Hamoud plays a vital role on various medical committees, including the committee for blood product transfusions at Rambam and the specialty committee within the hospital.

Contributions and Research Focus 🔬

Dr. Hamoud's research interests are broad, focusing on critical issues in cardiovascular medicine, diabetes, and novel COVID-19 treatments. He has investigated lipoprotein oxidation and atherosclerosis, as well as the enzyme heparanase and its impact on kidney injuries, fatty liver disease, and other conditions. His involvement in international clinical trials and research on lipid-modifying drugs and new oral anticoagulants highlights his commitment to advancing medical science.

Accolades and Recognition 🏅

Dr. Hamoud has received numerous awards throughout his career, recognizing his dedication to both medicine and education. Between 2003 and 2016, he was named an Excellent Lecturer by the Internal Medicine E Department at Rambam Health Care Campus. In 2008, he was also honored with an Excellence in Medicine award, further cementing his reputation as a distinguished medical professional.

Impact and Influence 🌍

Dr. Hamoud’s influence extends beyond academia and clinical practice. He has been actively involved in public health education, delivering lectures at local schools in his hometown of Majd Al-Kurum. His role as an examiner in Israel’s internal medicine specialization exams underscores his commitment to shaping the next generation of medical professionals. He has also contributed to the medical field through his membership in professional societies, including the European Society of Hypertension and the Israeli Society of Hypertension.

Legacy and Future Contributions 🌱

Dr. Hamoud's work in medical research, clinical practice, and education has left a lasting impact on the healthcare field in Israel and beyond. His ongoing roles in clinical research, his contributions to new therapies for chronic diseases, and his mentorship of future doctors ensure that his influence will continue to grow. As a leader in both medicine and research, his legacy is one of commitment to improving health outcomes and advancing scientific knowledge for the benefit of future generations

 

Publications

  • 📄"Gender-Specific Renoprotective Pathways in αMUPA Transgenic Mice Subjected to Acute Kidney Injury" 🐭
    Authors: Heba Abd Alkhaleq, Shadi Hamoud, Israel Hacker, Tony Karram, Ahmad Fokra, Aviva Kabala, Zaid Abassi
    Journal: International Journal of Molecular Sciences
    Year: 2024
  • 📄"Effects of Angiotensin 1-7 and Mas Receptor Agonist on Renal System in a Rat Model of Heart Failure" 🐀
    Authors: Ravit Cohen-Segev, Omri Nativ, Safa Kinaneh, Doron Aronson, Aviva Kabala, Shadi Hamoud, Tony Karram, Zaid Abassi
    Journal: International Journal of Molecular Sciences
    Year: 2023
  • 📄"Heparanase Inhibition Prevents Liver Steatosis in E₀ Mice" 🧬
    Authors: Safa Kinaneh, Walaa Hijaze, Lana Mansour-Wattad, Rawan Hammoud, Hisam Zaidani, Aviva Kabala, Shadi Hamoud
    Journal: Journal of Clinical Medicine
    Year: 2022

 

Maria Margariti | Medicine and Dentistry | Best Researcher Award

Posted on by Book of Award

Assoc Prof Dr. Maria Margariti | Medicine and Dentistry | Best Researcher Award

1st Department of Psychiatry, Medical School, National and Kapodistrian University of Athens | Greece

Author Profile 

Google Scholar

Early Academic Pursuits 🎓

Dr. Maria Margariti embarked on her academic journey at the National and Kapodistrian University of Athens, where she earned her Diploma in Medicine in 1989. Her dedication to psychiatry led her to complete a fellowship training program in community psychiatry in the UK in 1991-1992. By 1995, she had achieved her Psychiatric Specialty Licensure and continued her education with a Ph.D. in Psychiatric Education, which she completed in 2000. Her early academic foundation laid the groundwork for a successful career in psychiatry.

Professional Endeavors 🏥

Since 2002, Dr. Margariti has been an integral part of the National and Kapodistrian University of Athens, where she progressed from Lecturer to her current position as Associate Professor of Psychiatry. She has been pivotal in various leadership roles, including heading the psychiatric emergencies and outpatient clinic at Eginition Hospital. Additionally, she founded the Crisis Intervention and Management Unit for severe psychiatric disorders, showcasing her commitment to advancing psychiatric care.

Contributions and Research Focus 🔍

Dr. Margariti’s research primarily focuses on psychiatric education and the psychopathology of psychosis. Her extensive clinical observations led to the recognition of a complex emotional state called ‘Psychotic Arousal.’ This groundbreaking concept highlights an increased affective tone and symptoms of experiential alienation in acute psychosis. Her work has opened new avenues for understanding the neurobiology of emotions and consciousness in the context of psychiatric disorders.

Accolades and Recognition 🏆

Dr. Margariti’s contributions to the field have not gone unnoticed. She has published 45 journals and is cited 716 times, reflecting the impact of her research. She has been involved in developing clinical guidelines for treating schizophrenia and has served as an advisor in various professional psychiatric organizations. Her leadership roles and innovative research have solidified her reputation in the psychiatric community.

Impact and Influence 🌍

Through her educational initiatives, Dr. Margariti has shaped the training of numerous medical students and trainee psychiatrists. Her involvement in postgraduate courses and mentorship has significantly influenced the next generation of psychiatric professionals in Greece. By addressing critical aspects of psychiatric education and psychopathology, her work continues to resonate within the medical community.

Legacy and Future Contributions 🔮

Dr. Margariti’s pioneering research on ‘Psychotic Arousal’ is poised to leave a lasting legacy in psychiatric literature. As she continues to explore the complexities of acute psychosis, her findings may lead to enhanced diagnostic and therapeutic approaches in psychiatry. With her ongoing commitment to research and education, she is well-positioned to make further significant contributions to the field.

 

Publications

📝 Psychotic Arousal and the Psychopathology of Acute Schizophrenia: An Exploratory Study of the Experiential Emotional State in Acute Psychosis
Authors: MM Margariti, II Vlachos, D Mpourazana, P Aristotelidis, M Selakovic, ...
Journal: Journal of Clinical Medicine
Year: 2024

📝 Frequent visitors in a university psychiatric emergency department in Greece
Authors: I Vlachos, P Chondraki, P Magioglou, E Lempesi, D Bourazana, ...
Journal: European Psychiatry
Year: 2022

📝 The concept of psychotic arousal and its relevance to abnormal subjective experiences in schizophrenia. A hypothesis for the formation of primary delusions
Authors: MM Margariti, II Vlachos
Journal: Medical Hypotheses
Year: 2022

📝Psychiatric specialty training in Greece: Comparative analysis of educational programs (2000 vs 2014)
Authors: M Margariti, C Papageorgiou
Journal: Psychiatrike= Psychiatriki
Year: 2017